HMGA2 and cancer: During these replicative cycles, HMGA2 has also been postulated to either inhibit DNA damage response (DDR) mechanisms that ensure genomic stability at replication forks, which leads to increased DNA mutational rates at onset of tumorigenesis, or augment these DDR mechanisms to reduce replication recovery times after replication fork arrest in stem and cancer cells [22,174].